Jinyu Xia to Ritonavir
This is a "connection" page, showing publications Jinyu Xia has written about Ritonavir.
Connection Strength
0.897
-
Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients. Front Immunol. 2021; 12:580989.
Score: 0.308
-
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study. Trials. 2020 Jul 08; 21(1):622.
Score: 0.289
-
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. J Infect. 2020 07; 81(1):e1-e5.
Score: 0.282
-
Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020 05 18; 12(4):322-325.
Score: 0.018